Buy Piramal Pharma, target price Rs 115: Motilal Oswal

Piramal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.

By ETMarkets.com | Updated: Oct 31, 2023, 10.39 AM IST

Promoters held 35.02 per cent stake in the company as of 30-Sep-2023, while FIIs owned 32.37 per cent, DIIs 8.01 per cent.

Motilal Oswal Financial Services has buy call on Piramal Pharma Ltd. with a target price of Rs 115.0. The current market price of Piramal Pharma Ltd. is Rs 103.3.

Piramal Pharma Ltd., incorporated in the year 2020, is a Small Cap company (having a market cap of Rs 13546.99 Crore) operating in Pharmaceuticals sector.

Piramal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.

Financials
For the quarter ended 30-09-2023, the company has reported a Consolidated Total Income of Rs 1960.57 Crore, up 9.70 % from last quarter Total Income of Rs 1787.16 Crore and up 11.00 % from last year same quarter Total Income of Rs 1766.23 Crore. Company has reported net profit after tax of Rs -14.09 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 35.02 per cent stake in the company as of 30-Sep-2023, while FIIs owned 32.37 per cent, DIIs 8.01 per cent.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!